en

PRODUCT DETAIL

Metoject 50 mg/ml injekčný roztok

Code 6155C
MA number 44/0659/08-S
Product Form: sol inj 10x0,60 ml/30 mg (striek.napl.skl. so vsad.ihl.s bezpeč.systém.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AX Other immunosuppressants
L04AX03 Methotrexate
Shelf life: 24
Container: glass pre-filled syringe
Route of admin.: Subcutaneous, intramuscular and intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 19.12.2008
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Metoject 50 mg_ml injekčný roztok_10.2023.pdf  
SPC: SPC_Metoject 50 mg_ml injekčný roztok_10.2023.pdf  
Safety feature Yes
Data update: 12.04.2023
eu-flag.png sk-flag.png